Entity Common Stock, Shares Outstanding of HALOZYME THERAPEUTICS, INC. from 01 Aug 2011 to 10 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
HALOZYME THERAPEUTICS, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 01 Aug 2011 to 10 Feb 2026.
  • HALOZYME THERAPEUTICS, INC. Entity Common Stock, Shares Outstanding for the quarter ending 10 Feb 2026 was 118,017,000, a 4.2% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

HALOZYME THERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 118,017,000 -5,136,000 -4.2% 10 Feb 2026 10-K 17 Feb 2026 2025 FY
Q3 2025 117,597,000 -9,630,000 -7.6% 27 Oct 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 116,966,000 -9,712,280 -7.7% 31 Jul 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 123,221,000 -4,053,000 -3.2% 30 Apr 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 123,153,000 -3,671,800 -2.9% 11 Feb 2025 10-K 18 Feb 2025 2024 FY
Q3 2024 127,227,000 -4,871,110 -3.7% 24 Oct 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 126,678,280 -5,242,600 -4% 31 Jul 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 127,274,000 -4,406,440 -3.3% 30 Apr 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 126,824,800 -8,542,062 -6.3% 12 Feb 2024 10-K 20 Feb 2024 2023 FY
Q3 2023 132,098,110 -3,114,948 -2.3% 31 Oct 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 131,920,880 -5,858,490 -4.3% 31 Jul 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 131,680,440 -6,269,240 -4.5% 28 Apr 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 135,366,862 -2,336,648 -1.7% 14 Feb 2023 10-K 21 Feb 2023 2022 FY
Q3 2022 135,213,058 -5,573,962 -4% 31 Oct 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 137,779,370 -4,555,530 -3.2% 02 Aug 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 137,949,680 -4,436,250 -3.1% 04 May 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 137,703,510 14 Feb 2022 10-K 22 Feb 2022 2021 FY
Q3 2021 140,787,020 +5,603,980 +4.1% 25 Oct 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 142,334,900 +5,308,230 +3.9% 03 Aug 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 142,385,930 +6,570,990 +4.8% 05 May 2021 10-Q 10 May 2021 2021 Q1
Q3 2020 135,183,040 -11,356,550 -7.8% 28 Oct 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 137,026,670 -9,284,250 -6.3% 05 Aug 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 135,814,940 -9,694,230 -6.7% 06 May 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 138,226,070 -6,807,103 -4.7% 14 Feb 2020 10-K 24 Feb 2020 2019 FY
Q3 2019 146,539,590 +1,982,047 +1.4% 07 Nov 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 146,310,920 +2,006,680 +1.4% 31 Jul 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 145,509,170 +1,543,550 +1.1% 30 Apr 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 145,033,173 +1,956,583 +1.4% 14 Feb 2019 10-K 21 Feb 2019 2018 FY
Q3 2018 144,557,543 +2,200,543 +1.5% 30 Oct 2018 10-Q 06 Nov 2018 2018 Q3
Q2 2018 144,304,240 +2,388,930 +1.7% 31 Jul 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 143,965,620 +14,125,590 +11% 03 May 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 143,076,590 13 Feb 2018 10-K 20 Feb 2018 2017 FY
Q3 2017 142,357,000 +12,866,930 +9.9% 01 Nov 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 141,915,310 +12,501,230 +9.7% 01 Aug 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 129,840,030 +700,287 +0.54% 01 May 2017 10-Q 09 May 2017 2017 Q1
Q3 2016 129,490,070 +1,476,036 +1.2% 01 Nov 2016 10-Q 07 Nov 2016 2016 Q3
Q2 2016 129,414,080 +116,642,308 +913% 02 Aug 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 129,139,743 +2,435,608 +1.9% 02 May 2016 10-Q 09 May 2016 2016 Q1
Q3 2015 128,014,034 +2,626,951 +2.1% 02 Nov 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 12,771,772 -112,534,001 -90% 06 Aug 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 126,704,135 +2,195,337 +1.8% 24 Feb 2015 10-K 02 Mar 2015 2014 FY
Q3 2014 125,387,083 +11,358,487 +10% 05 Nov 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 125,305,773 +12,020,191 +11% 05 Aug 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 124,508,798 +11,385,898 +10% 05 May 2014 10-Q 12 May 2014 2014 Q1
Q3 2013 114,028,596 +1,323,504 +1.2% 04 Nov 2013 10-Q 08 Nov 2013 2013 Q3
Q2 2013 113,285,582 +593,150 +0.53% 05 Aug 2013 10-Q 07 Aug 2013 2013 Q2
Q1 2013 113,122,900 +679,528 +0.6% 25 Feb 2013 10-K 01 Mar 2013 2012 FY
Q3 2012 112,705,092 +9,013,449 +8.7% 31 Oct 2012 10-Q 08 Nov 2012 2012 Q3
Q2 2012 112,692,432 +9,072,788 +8.8% 01 Aug 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 112,443,372 30 Apr 2012 10-Q 07 May 2012 2012 Q1
Q3 2011 103,691,643 02 Nov 2011 10-Q 08 Nov 2011 2011 Q3
Q2 2011 103,619,644 01 Aug 2011 10-Q 05 Aug 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.